Biogenic silver nanomaterials synthesized from leaf extract exhibiting robust antimicrobial and anticancer activities: Exploring the therapeutic potential.

There is a surge in antibiotic consumption because of the emergence of resistance among microbial pathogens. In the escalating challenge of antibiotic resistance in microbial pathogens, silver nanoparticles (AgNPs)-mediated therapy has proven to be the most effective and alternative therapeutic strategy for bacterial infections and cancer treatment. This study aims to explore the potential of OsAgNPs derived from aqueous leaf extract as antimicrobial agents and anticancer drug delivery modalities. This study utilized a plant extract derived from (Tulsi) leaves to synthesize silver nanoparticles (OsAgNPs), that were characterized by FTIR, TEM, SEM, and EDX. OsAgNPs were assessed for their antibacterial and anticancer potential. TEM analysis unveiled predominantly spherical or oval-shaped OsAgNPs, ranging in size from 4 to 98 nm. The (MICs) of OsAgNPs demonstrated a range from 0.350 to 19.53 μg/ml against clinical, multidrug-resistant (MDR), and standard bacterial isolates. Dual labelling with ethidium bromide and acridine orange demonstrated that OsAgNPs induced apoptosis in HeLa cells. The OsAgNPs-treated cells showed yellow-green fluorescence in early-stage apoptotic cells and orange fluorescence in late-stage cells. Furthermore, OsAgNPs exhibited a concentration-dependent decrease in HeLa cancer cell viability, with an IC50 value of 90 μg/ml noted. The study highlights the remarkable antibacterial efficacy of OsAgNPs against clinically significant bacterial isolates, including antibiotic-resistant strains. These results position the OsAgNPs as prospective therapeutic agents with the potential to address the growing challenges posed by antibiotic resistance and cervical cancer.